City
Epaper

India's bioeconomy sees 16-fold rise to reach $165.7 billion in 10 years: Minister

By IANS | Updated: March 21, 2025 17:46 IST

New Delhi, March 21 India's bioeconomy has witnessed 16-fold rise in the last 10 years -- from $10 ...

Open in App

New Delhi, March 21 India's bioeconomy has witnessed 16-fold rise in the last 10 years -- from $10 billion in 2014 to an impressive $165.7 billion in 2024, the government said on Friday.

This exponential growth is a testament to the government's commitment to fostering biotechnology as a key pillar of India's future economic growth, said Union Minister Dr Jitendra Singh at the BIRAC Foundation Day ceremony in the national capital.

"In just 10 years, India's bio-economy has expanded from a modest $10 billion to $165.7 billion, far surpassing our initial target of $150 billion by 2025," Dr Singh stated, quoting the ‘IBER 2025’ report.

As per the report, the sector is contributing 4.25 per cent to the overall GDP. The sector has shown a CAGR of 17.9 per cent over the past four years, showcasing India’s potential as a global biotech powerhouse.

The minister also unveiled BioSaarthi, a pioneering global mentorship initiative aimed at nurturing biotech startups.

Designed as a six-month cohort, BioSaarthi will facilitate structured mentor-mentee engagements, offering personalised guidance to emerging entrepreneurs in the biotech sector.

The minister emphasised that this initiative will strengthen India’s biotech ecosystem by fostering innovation, enhancing industry-academia collaboration, and positioning Indian startups for global success.

The initiative would engage overseas experts, particularly from Indian diaspora as international mentors who would volunteer to give back to the society.

The minister also highlighted the recently approved BIO-E3 Policy —Biotechnology for Economy, Employment, and Environment — which aims to accelerate research, innovation, and entrepreneurship in the sector.

Dr Singh also announced that Assam has become the first state to adopt the BioE3 framework, marking a significant step toward pan-India implementation. India’s biotech startup ecosystem has grown from just 50 startups a decade ago to over 10,075 now.

India's gross expenditure on research and development (GERD) has more than doubled in the past decade, rising from Rs 60,196 crore in 2013-14 to Rs 1,27,381 crore in 2024.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

Other SportsWomen’s Euro: Beth Mead reflects on bench role in England’s run to SF, says ‘I love being on the pitch’

International"My entire life is at stake... appeal to Government to bring back my husband": Wife of Indian national abducted in Niger

NationalNow Order PVC Aadhaar Cards Online Without OTP Login – Here's How!

NationalPeople formed 'non-stop government' for third time, says Haryana CM

NationalFairPoint: It cannot be about 'patak patak-dubo dubo ke maarenge'

Technology Realted Stories

TechnologyIndia becomes global leader in fast payments as UPI processed 18.39 billion transactions in June

TechnologyForeign ownership of Samsung Electronics tops 50 pc again

TechnologyNearly 70 pc of Rajasthan’s power capacity comes from renewable energy: Pralhad Joshi

TechnologyIndia Cements slips into Rs 133 crore loss in Q1, revenue flat

TechnologyNearly 76,000 Indian startups now led by women: Minister